- Home
- OGI vs NKTR Comparison
OGI vs NKTR Comparison
Compare OGI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- NKTR
- Stock Information
- Founded
- OGI 2013
- NKTR 1990
- Country
- OGI Canada
- NKTR United States
- Employees
- OGI N/A
- NKTR N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- NKTR Health Care
- Exchange
- OGI Nasdaq
- NKTR Nasdaq
- Market Cap
- OGI 155.2M
- NKTR 160.4M
- IPO Year
- OGI N/A
- NKTR 1994
- Fundamental
- Price
- OGI $1.18
- NKTR $0.59
- Analyst Decision
- OGI
- NKTR Strong Buy
- Analyst Count
- OGI 0
- NKTR 6
- Target Price
- OGI N/A
- NKTR $4.92
- AVG Volume (30 Days)
- OGI 382.1K
- NKTR 2.2M
- Earning Date
- OGI 05-12-2025
- NKTR 05-08-2025
- Dividend Yield
- OGI N/A
- NKTR N/A
- EPS Growth
- OGI N/A
- NKTR N/A
- EPS
- OGI N/A
- NKTR N/A
- Revenue
- OGI $115,451,336.00
- NKTR $87,248,000.00
- Revenue This Year
- OGI $50.30
- NKTR N/A
- Revenue Next Year
- OGI $16.01
- NKTR N/A
- P/E Ratio
- OGI N/A
- NKTR N/A
- Revenue Growth
- OGI N/A
- NKTR N/A
- 52 Week Low
- OGI $0.85
- NKTR $0.43
- 52 Week High
- OGI $2.11
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- OGI 60.23
- NKTR 39.04
- Support Level
- OGI $1.09
- NKTR $0.57
- Resistance Level
- OGI $1.20
- NKTR $0.81
- Average True Range (ATR)
- OGI 0.06
- NKTR 0.06
- MACD
- OGI 0.01
- NKTR -0.01
- Stochastic Oscillator
- OGI 88.24
- NKTR 7.48
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.